Peroxisome proliferator-activated receptor α activation-mediated regulation of endothelin-1 production via nitric oxide and protein kinase C signaling pathways in piglet cerebral microvascular endothelial cell culture

Journal of Pharmacology and Experimental Therapeutics

Volumn 320, Issue 2, 2007, Pages 774-781

  Yakubu, Momoh A ^a   Nsaif, Rami H ^a   Oyekan, Adebayo O ^a  

^a TEXAS SOUTHERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ARGININE METHYL ESTER; BRADYKININ; CALPHOSTIN C; CLOFIBRATE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; HEMOGLOBIN; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C;

ANIMAL CELL; ARTICLE; BRAIN FUNCTION; CELL CULTURE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; NONHUMAN; PIGLET; PRIORITY JOURNAL; TRAUMATIC BRAIN INJURY; VASCULAR DISEASE;

ANIMALS; BRAIN; CLOFIBRATE; ENDOTHELIAL CELLS; ENDOTHELIN-1; MICROCIRCULATION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PPAR ALPHA; PROTEIN KINASE C; SIGNAL TRANSDUCTION; SWINE;

EID: 33846406390     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.104992     Document Type: Article

References (34)

1. Andaluz N, Zuccarello M, and Wagner KR (2002) Experimental animal models of intracerebral hemorrhage. Neurosurg Clin N Am 13:385-393.
2. Blanquart C, Mansouri R, Paumelle R, Fruchart JC, Staels B, and Glineur C (2004) The protein kinase C signaling pathway regulates a molecular switch between transactivation and transrepression activity of the peroxisome proliferatoractivated receptor alpha. Mol Endocrinol 18:1906-1918.
3. Boulanger C and Luscher TF (1990) Release of endothelin from the porcine aorta: inhibition by endothelium-derived nitric oxide. J Clin Investig 85:587-590.
4. Chih-Hao L, Ajay C, Ned U, Debbie L, William BA, Ronald EM, and Linda CK (2003) Transcriptional repression of atherogenic inflammation: modulation by PPAR delta. Science (Wash DC) 302:453-457.
5. Chinetti-Gbaguidi G, Fruchart JC, and Staels B (2005) Pleiotropic effects of fibrates. Curr Atheroscler Rep 7:396-401.
6. Delerive P, Martin-Nizard F, Chinetti G, Trottein F, Fruchart J-C, Najib J, Duriez P, and Staels B (1999) Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway. Circ Res 85:394-402.
7. Desvergne B and Wahli W (1999) Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 20:649-688.
8. Findlay JM, MacDonald RL, and Weir BK (1991) Current concepts of pathophysiology and management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Cerebrovasc Brain Metab Rev 3:336-361.
9. Goya K, Sumitani S, Xu X, Kitamura T, Yamamoto H, Kurebayashi S, Saito H, Kouhara H, Kasayama S, and Kawase I (2004) Peroxisome proliferator-activated receptor α agonists increase nitric oxide synthase expression in vascular endothelial cells. Arterioscler Thromb Vasc Biol 24:658-663.
10. Gray JP, Burns KA, Leas TL, Perdew GH, and Vanden Heuvel JP (2005) Regulation of peroxisome proliferator-activated receptor alpha by protein kinase C. Biochemistry 44:10313-10321.
11. Han SH, Quon MJ, and Koh KK (2005) Beneficial vascular and metabolic effects of peroxisome proliferator-activated receptor-alpha activators. Hypertension 46: 1086-1092.
12. Ignarro LJ (1990) Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol 30:535-560.
13. Irukayama-Tomobe Y, Miyauchi T, Kasuya Y, Sakai S, Goto K, and Yamaguchi I (2004) Activation of peroxisome proliferator-activated receptor-A decreases endothelin-1-induced p38 mitogen-activated protein kinase activation in cardiomyocytes. J Cardiovasc Pharmacol 44:S358-S361.
14. Israelian-Konaraki Z and Reaven PD (2005) Peroxisome proliferator- activated receptor-alpha and atherosclerosis: from basic mechanisms to clinical implications. Cardiol Rev 13:240-246.
15. Liu-Deryke X and Rhoney DH (2006) Cerebral vasospasm after aneurysmal subarachnoid hemorrhage: an overview of pharmacologic management. Pharmacotherapy 26:182-203.
16. MacDonald LR (2006) Management of cerebral vasospasm. Neurosurg Rev 29:179-193.
17. Macdonald RL and Weir BK (1991) A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 22:971-982.
18. Michelle BJ, Chen Z-P, Tiganis T, Stapleton D, Katsis F, Power DA, Sim AT, and Kemp B (2001) Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase. J Biol Chem 276:17625-17628.
19. Miyauchi T and Masaki T (1999) Pathophysiology of endothelin in the cardiovascular system. Annu Rev Physiol 61:391-415.
20. Moncada S, Palmer RM, and Higgs EA (1989) The biological significance of nitric oxide formation from L-arginine. Biochem Soc Trans 17:642-644.
21. + transport in the rat. BMC Pharmacol 4:1.
22. Paumelle R, Blanquart C, Briand O, Barbier O, Duhem C, Woerly G, Percevault F, Fruchart JC, Dombrowicz D, Glineur C, et al. (2006) Acute antiinflammatory properties of statins involve peroxisome proliferator-activated receptor-alpha via inhibition of the protein kinase C signaling pathway. Circ Res 98:361-369.
23. Ramzy D, Rao V, Tumiati LC, Xu N, Sheshgiri R, Miriuka S, Delgado DH, and Ross HJ (2006) Elevated endothelin-1 levels impair nitric oxide homeostasis through a PKC-dependent pathway. Circulation 114:I319-I326.
24. Rubanyi GM and Polokoff MA (1994) Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 46:325-415.
25. Sobey CG and Faraci FM (1998) Subarachnoid hemorrhage: what happens to the cerebral arteries? Clin Exp Pharmacol Physiol 25:867-876.
26. Touyz RM and Schiffrin EL (2006) Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications. Vasc Pharmacol 45:19-28.
27. Yakubu MA and Leffler CW (1996) Role of endothelin-1 in cerebral hematoma-induced modification of cerebral vascular reactivity in piglets. Brain Res 734:149-156.
28. Yakubu MA and Leffler CW (1999) Regulation of ET-1 biosynthesis in cerebral microvascular endothelial cells by vasoactive agents and PKC. Am J Physiol 276:C300-C305.
29. 2+ channels in cerebral microvascular endothelial cells and ET-1 biosynthesis. Am J Physiol 283:C1687-C1995.
30. Yakubu MA and Leffler CW (2005) Regulation of cerebral microvascular endothelial cell cyclooxygenase-2 message and activity by blood derived vasoactive agents. Brain Res Bull 68:150-156.
31. Yakubu MA, Liliom K, Tigyi GJ, and Leffler CW (1997) Role of lysophosphatidic acid in endothelin-1- and hematoma-induced alteration of cerebral microcirculation. Am J Physiol 273:R703-R709.
32. Yakubu MA, Shibata M, and Leffler CW (1994) Subarachnoid hematoma attenuates vasodilation and potentiates vasoconstriction induced by vasoactive agents in newborn pigs. Pediatr Res 36:589-594.
33. 4 and ET-1 in piglet: role of prostanoids. Pediatr Res 38:119-123.
34. Ziouzenkova O and Plutzky J (2004) Lipolytic PPAR activation: new insights into the intersection of triglycerides and inflammation? Curr Opin Clin Nutrx Metab Care 7:369-375.